Evidence map›Paper›PMID 36865331›Full record

ArticleResearch square2023

Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer.

A W Adamson, Y C Ding, L Steele, L A Leong, R Morgan, M T Wakabayashi, E S Han, T H Dellinger, P S Lin, A A Hakim and 6 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

A W AdamsonDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte CA.
Y C DingDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte CA.
L SteeleDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte CA.
L A LeongFormerly, Department of Medical Oncology, City of Hope National Medical Center, Duarte CA.
R MorganFormerly, Department of Medical Oncology, City of Hope National Medical Center, Duarte CA.
M T WakabayashiCurrently at Regeneron Pharmaceuticals Inc, Formerly City of Hope National Medical Center, Duarte CA.
E S HanDepartment of Surgery, City of Hope National Medical Center, Duarte CA.
T H DellingerDepartment of Surgery, City of Hope National Medical Center, Duarte CA.
P S LinFormerly, Department of Surgery, City of Hope National Medical Center, Duarte CA.
A A HakimDepartment of Surgery, City of Hope National Medical Center, Duarte CA.
S WilczynskiDepartment of Pathology, City of Hope National Medical Center, Duarte CA.
C D WardenDepartment of Integrative Genomics Core, Beckman Research Institute of City of Hope, Duarte CA.
S TaoDepartment of Integrative Genomics Core, Beckman Research Institute of City of Hope, Duarte CA.
V BedellCytogenetics Core, City of Hope National Medical Center, Duarte CA.
M C CristeaFormerly, Department of Medical Oncology, City of Hope National Medical Center, Duarte CA.
S L NeuhausenDepartment of Population Sciences, Beckman Research Institute of City of Hope, Duarte CA.
City Of Hope National Medical Center · US

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
NCI NIH HHS P30 CA033572
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36865331
PMCPMC9980206
OpenAlexW4321373853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.